Equitec Proprietary Markets »

Mirati Therapeutics shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1M 70k 58.75

More positions owned by Equitec Proprietary Markets

United States Steel Corporation Call Option (X)
Super Micro Computer Call Option (SMCI)
Applied Digital Corp Com New (APLD)
NVIDIA Corporation (NVDA)
B. Riley Financial (RILY)
Capri Holdings SHS (CPRI)
Microstrategy Cl A New (MSTR)
Fusion Pharmaceuticals Call Option (FUSN)
Amedisys (AMED)
Brookfield Infrastructure Com Sb Vtg Shs A (BIPC)
Vizio Hldg Corp Cl A Com (VZIO)
Angel Oak Finl Strategies In Com Ben Int (FINS)
Cannae Holdings (CNNE)
Doubledown Interactive Co Lt Ads (DDI)
American Equity Investment Life Holding (AEL)

View all positions for Equitec Proprietary Markets

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics